Get startedLog in
    Picture of Genmab A/S logo

    GMAB — Genmab A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapFalling Star
    All News

    Brief: Genmab Says Investigational Rinatabart Sesutecan (Rina-S) Continues To Show Encouraging Antitumor Activity

    Picture of Genmab A/S logoGenmab A/S
    17/03/2025 16:25
    March 17 (Reuters) - Genmab A/S GMAB.CO:

INVESTIGATIONAL RINATABART SESUTECAN (RINA-S®) CONTINUES TO SHOW ENCOURAGING ANTITUMOR ACTIVITY IN PATIENTS WITH ADVANCED OVARIAN CANCER

Source text: ID:nBw5WlkTja

Further company coverage: GMAB.CO

 (((( Reuters.Briefs@thomsonreuters.com ;));))

    Recent news on Genmab A/S

    See all news